SMU Associate Professor Gao Yini spearheads an award-winning project to assess the short- and long-term effects of preventive healthcare policies in Singapore.

Using an emulated target trial—a rigorous study design that approximates a randomized clinical trial using real-world data—researchers compared outcomes among patients who received rasburicase within 12 hours of developing TLS with those who received it later or not at all. Patients who received early rasburicase were about one-third less likely to require dialysis or die during their hospital stay compared with those who received delayed or no rasburicase treatment.

Researchers at Columbia University have discovered a new type of cell that protects lung cancers from attacks by the immune system.

Albany, NY – State University of New York Chancellor John B. King Jr. today visited the Great New York State Fair on Student Youth Day. For the first time, current SUNY students with a valid student ID card or incoming SUNY students with an admission letter are receiving free admission on Student Youth Day. SUNY campuses are also showcasing agriculture, battery technologies, healthcare, and more.

Pre-cancerous blood cells can actively reshape their surroundings, prematurely aging cells in the bone marrow to create conditions that favor their own growth and, potentially, increase the risk of blood cancer, according to a new study by researchers at The Jackson Laboratory (JAX).

Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific therapies, manufactured from patients’ own immune cells, could also help cure autoimmune diseases. Six patients with particularly severe rheumatoid arthritis have now received this treatment at Charité – Universitätsmedizin Berlin. In the journal Nature Medicine*, the researchers report the results from the world’s first clinical trial of its kind: Disease activity decreased substantially in all participants. By the end of the observation period, three of the patients no longer required any medication for rheumatoid arthritis.

When researchers at Lund University investigated how the molecule UM171 works, a molecule used to make blood stem cells multiply, they made an unexpected connection. The results provide new insights into how one of the most common malignant brain tumours in children could be treated in the future.